These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8309863)
1. Lipoproteins and apolipoproteins. Making use of their metabolic properties to individualize therapy. Kottke BA Postgrad Med; 1994 Feb; 95(2):51-3, 57-8, 63-5. PubMed ID: 8309863 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of hyperlipoproteinemia by plasma exchange]. Homma Y Nihon Rinsho; 1992 Jan; 50 Suppl():370-3. PubMed ID: 1578709 [No Abstract] [Full Text] [Related]
4. [Initial experiences with the effect of chronic intermittent electromyostimulation in patients with hyperlipoproteinemias and arterial circulatory disorders]. Kuklinski B; Gibas P; Köhler H; Grossmann KD; Rühlmann C; Zimmermann R; Voigt H; Reuter W; Duck HJ; Bühnert G Z Gesamte Inn Med; 1988 Jan; 43(1):6-11. PubMed ID: 3258458 [TBL] [Abstract][Full Text] [Related]
5. Eicosanoids, apolipoproteins, lipoprotein particles, and atherosclerosis. Proceedings of the Fourth International Colloquium. March 17-19, 1988, Brussels, Belgium. Adv Exp Med Biol; 1988; 243():1-362. PubMed ID: 3223414 [No Abstract] [Full Text] [Related]
6. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II. Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287 [TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolemia: genetic, dietary, and pharmacologic interrelationships. Levy RI Prog Clin Biol Res; 1981; 67():351-60. PubMed ID: 7029563 [No Abstract] [Full Text] [Related]
8. The inflammation: lipoprotein cycle. Barter P Atheroscler Suppl; 2005 May; 6(2):15-20. PubMed ID: 15823492 [TBL] [Abstract][Full Text] [Related]
9. [Most recent state of therapy of various forms of hyperlipoproteinemia]. Widhalm K Vasa Suppl; 1990; 30():14-5. PubMed ID: 2075566 [No Abstract] [Full Text] [Related]
10. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
11. [Genetic studies in familial hyperlipoproteinemia, and therapeutic implications]. de Gennes JL Ann Biol Clin (Paris); 1988; 46(1):1-3. PubMed ID: 3389574 [No Abstract] [Full Text] [Related]
12. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Wolfrum C; Poy MN; Stoffel M Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583 [TBL] [Abstract][Full Text] [Related]
14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
15. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. Berbée JF; Havekes LM; Rensen PC J Endotoxin Res; 2005; 11(2):97-103. PubMed ID: 15949136 [TBL] [Abstract][Full Text] [Related]